BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31719898)

  • 1. A Novel Nanoconjugate of Landomycin A with C
    Bilobrov V; Sokolova V; Prylutska S; Panchuk R; Litsis O; Osetskyi V; Evstigneev M; Prylutskyy Y; Epple M; Ritter U; Rohr J
    Cell Mol Bioeng; 2019 Feb; 12(1):41-51. PubMed ID: 31719898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of C
    Prylutska S; Grynyuk I; Skaterna T; Horak I; Grebinyk A; Drobot L; Matyshevska O; Senenko A; Prylutskyy Y; Naumovets A; Ritter U; Frohme M
    Arch Toxicol; 2019 May; 93(5):1213-1226. PubMed ID: 30989314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoronavirus Activity of Water-Soluble Pristine C
    Hurmach V; Platonov M; Prylutska S; Klestova Z; Cherepanov V; Prylutskyy Y; Ritter U
    Adv Exp Med Biol; 2021; 1352():159-172. PubMed ID: 35132600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanocomplex of C
    Prylutska S; Politenkova S; Afanasieva K; Korolovych V; Bogutska K; Sivolob A; Skivka L; Evstigneev M; Kostjukov V; Prylutskyy Y; Ritter U
    Beilstein J Nanotechnol; 2017; 8():1494-1501. PubMed ID: 28900603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.
    Panchuk RR; Prylutska SV; Chumakl VV; Skorokhyd NR; Lehka LV; Evstigneev MP; Prylutskyy YI; Berger W; Heffeter P; Scharff P; Ritter U; Stoika RS
    J Biomed Nanotechnol; 2015 Jul; 11(7):1139-52. PubMed ID: 26307837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C
    Grebinyk A; Prylutska S; Buchelnikov A; Tverdokhleb N; Grebinyk S; Evstigneev M; Matyshevska O; Cherepanov V; Prylutskyy Y; Yashchuk V; Naumovets A; Ritter U; Dandekar T; Frohme M
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31717305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexation with C
    Grebinyk A; Prylutska S; Grebinyk S; Prylutskyy Y; Ritter U; Matyshevska O; Dandekar T; Frohme M
    Nanoscale Res Lett; 2019 Feb; 14(1):61. PubMed ID: 30788638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy.
    Shi J; Liu Y; Wang L; Gao J; Zhang J; Yu X; Ma R; Liu R; Zhang Z
    Acta Biomater; 2014 Mar; 10(3):1280-91. PubMed ID: 24211343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts.
    Liao F; Saitoh Y; Miwa N
    Oncol Res; 2011; 19(5):203-16. PubMed ID: 21542456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does C
    Borowik A; Prylutskyy Y; Kawelski Ł; Kyzyma O; Bulavin L; Ivankov O; Cherepanov V; Wyrzykowski D; Kaźmierkiewicz R; Gołuński G; Woziwodzka A; Evstigneev M; Ritter U; Piosik J
    Colloids Surf B Biointerfaces; 2018 Apr; 164():134-143. PubMed ID: 29413590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
    Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
    Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects and hematotoxicity of C
    Prylutska SV; Lynchak OV; Kostjukov VV; Evstigneev MP; Remeniak OV; Rybalchenko VK; Prylutskyy YI; Ritter U; Scharff P
    Exp Oncol; 2019 Jun; 41(2):106-111. PubMed ID: 31262160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and properties of novel water-soluble fullerene-glycine derivatives as new materials for cancer therapy.
    Jiang G; Yin F; Duan J; Li G
    J Mater Sci Mater Med; 2015 Jan; 26(1):5348. PubMed ID: 25578702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C
    Hurmach Y; Rudyk M; Prylutska S; Hurmach V; Prylutskyy YI; Ritter U; Scharff P; Skivka L
    Mol Pharm; 2020 Sep; 17(9):3622-3632. PubMed ID: 32673486
    [No Abstract]   [Full Text] [Related]  

  • 15. Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules.
    Skamrova GB; Laponogov I; Buchelnikov AS; Shckorbatov YG; Prylutska SV; Ritter U; Prylutskyy YI; Evstigneev MP
    Eur Biophys J; 2014 Jul; 43(6-7):265-76. PubMed ID: 24748122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of dextran stabilized fullerene C
    Biby TE; Prajitha N; Ashtami J; Sakthikumar D; Maekawa T; Mohanan PV
    Brain Res Bull; 2020 Feb; 155():191-201. PubMed ID: 31786269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of photoexcited C
    Franskevych D; Prylutska S; Grynyuk I; Pasichnyk G; Drobot L; Matyshevska O; Ritter U
    Bioimpacts; 2019; 9(4):211-217. PubMed ID: 31799157
    [No Abstract]   [Full Text] [Related]  

  • 18. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
    Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U
    Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Influence of Water-Soluble PEG-Functionalized C
    Piotrowski P; Klimek K; Ginalska G; Kaim A
    Materials (Basel); 2021 Mar; 14(6):. PubMed ID: 33810193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C
    Skivka LM; Prylutska SV; Rudyk MP; Khranovska NM; Opeida IV; Hurmach VV; Prylutskyy YI; Sukhodub LF; Ritter U
    Cancer Nanotechnol; 2018; 9(1):8. PubMed ID: 30416604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.